Guangzhou Gloria Biosciences Co., Ltd. Sustainability Profile
Guangzhou Gloria Biosciences Co., Ltd., commonly referred to as Gloria Biosciences, is a leading player in the biotechnology industry, headquartered in Guangzhou, China. Established in 2009, the company has made significant strides in the development of innovative biopharmaceuticals and diagnostic products, focusing on areas such as molecular diagnostics and therapeutic solutions. With a commitment to quality and innovation, Gloria Biosciences offers a range of unique products, including advanced reagents and diagnostic kits that cater to both clinical and research applications. The company has positioned itself as a trusted partner in the global market, achieving notable milestones in research and development. Its dedication to excellence has earned it recognition within the industry, solidifying its reputation as a key contributor to the advancement of biosciences.
DitchCarbon Score
How does Guangzhou Gloria Biosciences Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Guangzhou Gloria Biosciences Co., Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Guangzhou Gloria Biosciences Co., Ltd.'s reported carbon emissions
Guangzhou Gloria Biosciences Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. This lack of data suggests that Guangzhou Gloria Biosciences may be in the early stages of developing its climate commitments or may not yet have formalised its sustainability strategy. In the context of the biotechnology industry, many companies are increasingly focusing on carbon neutrality and setting science-based targets to mitigate climate impact. However, without specific emissions data or reduction initiatives, it is challenging to assess Guangzhou Gloria Biosciences' position relative to industry standards. As the company progresses, it may consider adopting frameworks such as the Science Based Targets initiative (SBTi) to align its operations with global climate goals.
How Carbon Intensive is Guangzhou Gloria Biosciences Co., Ltd.'s Industry?
How Carbon Intensive is Guangzhou Gloria Biosciences Co., Ltd.'s Location?
Guangzhou Gloria Biosciences Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guangzhou Gloria Biosciences Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
